Declan Egan has joined the spinal and catastrophic injury case management team at HCML.
HCML has also strengthened the specialist team with the promotion of Kate Barton to clinical operations manager.
Egan, a qualified osteopath experienced in spinal conditions and fractures who has also managed complex polytrauma, persistent pain and intricate amputee rehabilitation, joins HCML from 3d Rehabilitation, where he was clinical operations manager.
He was previously rehabilitation case manager at Argent Rehabilitation and an occupational health case manager for FirstAssist/Capita.
In his new role, Egan will explore innovative orthotics and the role of vocational routine in rehabilitation.
Barton, a front-line registered paramedic and disability specialist, joined HCML in 2015 from the London Ambulance Service as a rehabilitation case manager.
She has a reputation for intensive management of trauma, complex, multiple and serious injuries, complex orthopaedic care, minor brain injury and long-term accident-related illnesses and conditions, including mental health.
Barton said: “As a paramedic, you are with people at the most frightening experiences in their lives, which has given me a huge understanding of people’s experiences and building personalised rehabilitation plans and putting them into practice.”
HCML chief executive Keith Bushnell said: “We have totally transformed our multi-track and catastrophic case-load in recent years largely by attracting the best specialist case managers, with a team that covers the UK in full. We continue to hire the best specialists who either want to work or in management, to re-build lives.”
“We are thrilled to welcome Declan and to congratulate Kate on her new role.”
HCML recently launched a comprehensive one-stop treatment service for insurers and law firms to coordinate hospital consultant appointments, surgery and diagnostic treatments.
The rehabilitation and case management firm said the new service will deliver a faster, cheaper, better patient journey and could offer savings of more than 10% in treatment management costs.